New Studies Link Rising Newborn Bleeding Cases to Missed Vitamin K Injections
Published by
Kosmos Consult3 min read
Two large US studies published in November 2026 found rising rates of vitamin K deficiency and bleeding among newborns, alongside an increase in the number of infants who did not receive the routine vitamin K injection at birth.

A newborn receiving an intramuscular injection
On this page
A preventable risk is drawing attention again
Vitamin K is essential for normal blood clotting. Newborns naturally have very low stores of the vitamin because only small amounts cross the placenta during pregnancy, and breast milk contains relatively little.
Without enough vitamin K, an infant can develop vitamin K deficiency bleeding (VKDB). The condition may cause bleeding in the intestines, under the skin or inside the brain. Some cases become life-threatening before parents notice any warning signs.
Two studies published in JAMA and JAMA Pediatrics on November 5, 2026, have brought renewed attention to this preventable risk.
What the studies found
A study published in JAMA examined records from approximately 5.24 million infants born in the United States between 2017 and 2025.
Researchers found that the proportion of newborns without documented intramuscular vitamin K administration rose from 3.1% in 2017 to 6.8% in 2025. Infants who did not receive the injection had a 47% higher adjusted risk of recorded bleeding during their first six months than those who received it.
The difference was more pronounced for bleeding inside the brain. The study recorded 33 cases per 10,000 births among infants without the injection, compared with 13.2 per 10,000 among those who received it.
A separate JAMA Pediatrics study examined more than 11 million infants and also found that vitamin K supplementation declined while diagnoses of vitamin K deficiency and vitamin K deficiency bleeding increased between 2017 and 2025.
These findings point in the same direction. They do not, by themselves, establish that every increase in bleeding was caused by refusal of the injection.
Why newborns need vitamin K
Vitamin K helps the body produce proteins required for blood clotting. Adults obtain it through food and intestinal bacteria, but newborns begin life with limited stores.
VKDB can appear during the first 24 hours, during the first week, or later in infancy. The late form can occur up to six months after birth, sometimes in babies who previously appeared healthy.
The US Centers for Disease Control and Prevention notes that many affected infants show no warning signs before a serious bleeding episode. This makes prevention particularly important.
What health authorities recommend
The American Academy of Pediatrics recommends that newborns receive vitamin K shortly after birth. For infants weighing more than 1,500 grams, its guidance specifies a single 1 mg intramuscular dose within six hours of birth. Smaller preterm infants require a weight-based dose.
The CDC identifies the injection as the most reliable way to prevent VKDB. Oral vitamin K is not considered an equivalent substitute under the American Academy of Pediatrics' guidance because absorption can vary and adequate protection may not be achieved.
Parents who have concerns about the injection should discuss them with their obstetrician or paediatrician before delivery. This gives the family time to understand the benefits, address safety questions and make an informed decision with a qualified clinician.
What the findings mean
The studies do not suggest that every infant who misses the injection will develop a bleeding disorder. They show that the risk is higher among infants who do not receive it, including the risk of serious intracranial bleeding.
The findings also remind healthcare workers that a rare condition can return to clinical attention when preventive care becomes less consistent. Clear conversations with parents, reliable newborn care and early recognition of unexplained bleeding remain essential.
Sources: JAMA study of 5.24 million infants · JAMA Pediatrics study · CDC guidance on vitamin K deficiency bleeding · American Academy of Pediatrics policy statement


